RET c.2428_2430delinsTGA ;(p.G810*)

Variant ID: 10-43615014-GGC-TGA

NM_020975.4(RET):c.2428_2430delinsTGA;(p.G810*)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


A comprehensive overview of the relationship between RET gene and tumor occurrence.

Frontiers In Oncology
Zhao, Lu L; Wang, Na N; Zhang, Dou D; Jia, Yingjie Y; Kong, Fanming F
Publication Date: 2023

Variant appearance in text: RET: G810X
PubMed Link: 36865807
Variant Present in the following documents:
  • Main text
  • fonc-13-1090757.pdf
View BVdb publication page



RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.

Cancers
Kucharczyk, Tomasz T; Krawczyk, Paweł P; Kowalski, Dariusz M DM; Płużański, Adam A; Kubiatowski, Tomasz T; Kalinka, Ewa E
Publication Date: 2022-10-27

Variant appearance in text: RET: G810X
PubMed Link: 36358717
Variant Present in the following documents:
  • Main text
  • cancers-14-05298.pdf
View BVdb publication page



RET signaling pathway and RET inhibitors in human cancer.

Frontiers In Oncology
Regua, Angelina T AT; Najjar, Mariana M; Lo, Hui-Wen HW
Publication Date: 2022

Variant appearance in text: RET: G810X
PubMed Link: 35957881
Variant Present in the following documents:
  • Main text
  • fonc-12-932353.pdf
View BVdb publication page



Kinase drug discovery 20 years after imatinib: progress and future directions.

Nature Reviews. Drug Discovery
Cohen, Philip P; Cross, Darren D; Jänne, Pasi A PA
Publication Date: 2021-07

Variant appearance in text: RET: G810X
PubMed Link: 34002056
Variant Present in the following documents:
  • Main text
  • 41573_2021_Article_195.pdf
View BVdb publication page